Member Info for Pingu777

Plus the paediatric trial end date, even tho only just starting, has been given the same end date.

Definitely not very hard and fast.

9 patients sounds like enough for me for phase one in both children and adults.

Could be completed rather quickly with fair winds.

Green box waffle continues. Whilst HMS unsinkable steams ahead.

Trial Progress and visibility accelerates. Everything else is just noise.

7 post Stevey is here for the bantz haha

I’m getting the feeling that you don’t know what you’re talking about either. They’re all coming out!

Good for lols though. Keep it up.

Let it Roll, as if he’s still posting bo77ocks here?!?!?

Stop replying to him. He’s just an attention seeker and doesn’t know anything about HEMO. Nothing that comes out of his mouth is worthy of any real consideration.

Just craves attention.

In the bin, in the bin, in the bin!

Vlads final challenge with HEMO was to increase visibility and obtain the recognition his company HG FT 1 deserves.

These prestigious get togethers are incredibly beneficial and imperative to HEMO reaching the heights I feel the science is capable of.

The potential access to huge funding deals such events offer is very exciting and can only help to enhance HEMOs reputation.

Day 28 for P3 tomorrow. At which point Adult cohort 2 patient 1 and the first child patient can begin being recruited. Pretty sure Dr Short will have them lined up already to go at MDA. I can see things moving rather swiftly from here.

Im confident getting the paediatric trial up and running will have a significant impact on the current value of HG CT 1 and consequently the share price.

An exciting period coming up.

The next RNS we get should confirm this!!!

Then its IRB approval to commence the peds trial and next adult and child patients.

If you're not looking forward to all of this playing out you must be nuts.

How many other treatments can boast such first cohort results? No bone marrow transplants, p1 over 6 months survival. Quality of life off the charts in comparison to existing standard of care.

All the people moaning about the SP are trading it. Anyone with any sense just buys as low as possible and holds til things come to fruition. Everything else inbetween is noise.

Similar result on the peds trial and there'll be a queue around the block throwing billions at HEMO. And I'm well informed that HG CT 1 is expected to work better on children.

Great value entry with upcoming SP catalysts piling up to be released over the next couple of weeks. Enjoy.

I don’t think there are too many days that buying HEMO stock under £10 will be possible. IMO.

I was thinking more £20+. £100m+ market cap.

Paediatric trial commencement is the golden goose of CAR T and once it begins its like we're finally letting Big Pharma have a peak at it. Its significance is not be lost on retail investors either.

MDA want things to move as swiftly as possible and we can now fund its expeditious commencement.

So let’s say p3 ticks all safety boxes (as I expect) in the RNS is in the next few days. How quickly can we get the paediatric trial up and running? IRB approval needed at MDA then it’s time to get a child recruited.

With the cash we have I can see this all happening rather quickly.

These upcoming updates are the facts that will super charges the SP in my opinion.

Target share price anyone at peds trial commencement ?

Alde,

Go play with your toys. You’re so far out of your depth I’ve had to call the lifeguard for you.

Someone give me a shout if Alde shares his scientific CV which suggests we should begin to take him seriously in discussions with Haywain.

We’ve begun in auction every day for the last week or more. Warrants are long gone.

That Alder is NEVER still here? Green box central.

Knows it all that lad. Main character syndrome. The more he talks, the less he knows. Sending hugs. Can't be easy when you have no mates.

Hedge,

I blocked Alder ages ago. Helps not having to read the tripe!

Goo luck to you. I remain very very relaxed with my position. Looking forward to P3 safety update, IRB approval and next patients selection (child and adult p4).

We're in an incredible position now with the cash to get patients through as quickly as MDA can get them treated within the protocol.

Onwards and upwards.

Thanks Ralph.

If you read anything you’d know there is no headroom to do this til Feb (Nov headroom going on CLNs).

Cheers mate.

Warrant stock was Forward sold.

The share price big drops should confirm that. They’re done with.

Much ado about nothing.

We don’t need to use our lab any more for CAR T.

It’s become much cheaper and slicker outsourcing.

*Once

Phase 2, 3 and one authorised by FDA for use Saint?